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Background: Bariatric surgery is an effective treatment to obtain weight loss in severely obese patients. The feasibility
and safety of bariatric robotic surgery is the topic of this review.
Methods: A search was performed on PubMed, Cochrane Central Register of Controlled Trials, BioMed Central, and
Web of Science.
Results: Twenty-two studies were included. Anastomotic leak rate was 8.51% in biliopancreatic diversion. 30-day
reoperation rate was 1.14% in Roux-en-Y gastric bypass and 1.16% in sleeve gastrectomy. Major complication rate in
Roux-en-Y gastric bypass resulted higher than in sleeve gastrectomy ( 4,26% vs. 1,2%). The mean hospital stay was
longer in Roux-en-Y gastric bypass (range 2.6-7.4 days).
Conclusions: The major limitation of our analysis is due to the small number and the low quality of the studies, the
small sample size, heterogeneity of the enrolled patients and the lack of data from metabolic and bariatric outcomes.
Despite the use of the robot, the majority of these cases are completed with stapled anastomosis. The assumption that
robotic surgery is superior in complex cases is not supported by the available present evidence. The major strength of
the robotic surgery is strongly facilitating some of the surgical steps (gastro-jejunostomy and jejunojejunostomy
anastomosis in the robotic Roux-en-Y gastric bypass or the vertical gastric resection in the
robotic sleeve gastrectomy).
Keywords: Morbid obesity, Bariatric surgery, Robotic, Roux-en-Y gastric bypass, Robot assisted, Gastric bypass,
Sleeve gastrectomy, Gastric banding, Duodenal switch, Surgical outcomes, Complications, Anastomotic leakBackground
The increased prevalence of obesity in the general population
over the past 30 years encouraged researches focused
on the development of new treatment options to achieve
long-lasting weight loss. Besides noninvasive conservative
treatments (e.g. lifestyle modifications, medical treatment,
and behavioral therapy), bariatric surgery is now playing
an important role in the treatment for obesity. In 1991 the
National Institutes of Health Conference Statement on
Gastrointestinal Surgery for Severe Obesity developed a
consensus stating that bariatric surgery was the most
effective treatment for obesity since it is associated with* Correspondence: renzicla@virgilio.it
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reproduction in any medium, provided the orgood long-term results in terms of weight loss, glycemic
control and decreased mortality [1]. It is widely recognized
the growing incidence of obesity and diabetes mellitus as
one of the major public burden in the western countries
[2]. Current pharmacotherapy provides improvements in
only less than 50% of patients with moderate to severe
type 2 diabetes mellitus (T2DM). In the United States
Roux-en-Y gastric bypass (RYGB) represents the most
common bariatric surgical procedure [3]. Adam et al., in
their Clinical Controlled Trial, enrolled 1.156 severely
obese patients (BMI ≥ 35 kg/m2); they demonstrated that
the RYGB surgery induced a significant weight loss, the
best health-related quality of life and reduction of major
obesity-related complications [4]. The only limit of bariatric
surgery is represented by elevate peri-operative morbidity
and mortality; in the attempt to reduce and limit thisl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 PRISMA flow chart of literature search.
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http://www.biomedcentral.com/1471-2482/13/53important issue, Minimally Invasive Surgical techniques,
initially laparoscopic and then robotic, are becoming more
and more frequent [5]. The feasibility and safety are still
debated. In 2011 a meta-analysis by Markar highlighted a
decreased anastomotic stricture rate in patients undergoing
Robotic RYGB (RRYGB) compared to the traditional
laparoscopic approach (P = 0.04) [6]. Recently Hagen et al.
demonstrated that RRYGB reduced cost of surgery by
avoiding the anastomosis-related complications [7]; this
was in contrast with the results presented by Scozzari et al.
[8]. In their study they concluded that RRYGBP does not
associate with significant shorter hospital stay and fewer
complications compared to the traditional laparoscopic
procedure [7,8]. Recently, a number of studies were
published on this subject, for this reason, despite
three systematic review were already published [9-11],
a new systematic one was needed in order to evaluate the
present state of the literature on robotic bariatric surgery.
Methods
A systematic literature search was performed on PubMed,
Cochrane Central Register of Controlled Trials, BioMed
Central and on Web of Science from January 2003 to
November 2012. The Preferred Reporting Items forSystematic Reviews and Meta-analyses (PRISMA) was
followed 005B [12]. Additional file 1. The following search
strategies were used in PubMed:
– Robot-assisted [All Fields] AND ("bariatric
surgery"[MeSH Terms] OR ("bariatric"[All Fields] AND
"surgery"[All Fields]) OR "bariatric surgery"[All Fields])
– Robot-assisted [All Fields] AND ("gastric
bypass"[MeSH Terms] OR ("gastric"[All Fields]
AND "bypass"[All Fields]) OR "gastric bypass"
[All Fields] OR "roux en y gastric bypass"[All Fields])
Robot-Assisted[All Fields] AND Sleeve[All Fields]
AND ("gastrectomy"[MeSH Terms] OR
"gastrectomy"[All Fields])
– ("robotics"[MeSH Terms] OR "robotics"[All Fields] OR
"robotic"[All Fields]) AND ("bariatric surgery"[MeSH
Terms] OR ("bariatric"[All Fields] AND "surgery"
[All Fields]) OR "bariatric surgery"[All Fields])
– ("robotics"[MeSH Terms] OR "robotics"
[All Fields] OR "robotic"[All Fields]) AND
("Band"[Journal] OR "band"[All Fields])
All titles and abstracts were assessed to select those
focusing on robotic bariatric surgery. Subsequently,
Table 1 Characteristics of the included studies: setting and technique
Study* Years of
the study
City Nation Type of trial N. of patients Author’s definition of Robotic treatment Type of reatment Type of technique
Abdalla [15] 2012 2008-2011 São Paulo, Brasil Case series 27 Robotic assisted gastric band placements 6 Gastric and placements,
5 Vertica gastrectomies and
16 Gastr by-pass in Roux-en-Y
NR1
Robotic assisted vertical gastrectomies
Robotic asssisted gastric by-pass in Roux-en-Y
Buchs [16] 2012 2006-2010 Geneva, Switzerland Case series 167 Robotic-assisted Roux-en-Y gastric bypass Roux-en gastric bypass Laparoscopic-Robotic
Hagen [7] 2012 1997-2010 Geneva, Switzerland CCT 143 Robotic-assisted Roux-en-Y gastric bypass Roux-en gastric bypass Laparoscopic-Robotic
Tieu [17] 2012 2002-2010 Houston, USA Case series 1100 Robotic-assisted Roux-en-Y gastric bypass Roux-en gastric bypass Laparoscopic-Robotic
Vilallonga [18] 2012 2010-2011 Barcelona, Spain Case series 32 Robot-Assisted Sleeve Gastrectomy Sleeve G strectomy Fully Robotic
Ayloo [19] 2011 2007 - 2010 Chicago, USA CCT 30 Robot-Assisted Sleeve Gastrectomy Sleeve G strectomy Fully Robotic
Diamantis [20] 2011 2008-2009 Athens, Greece CCT 19 Robotic Sleeve Gastrectomy Sleeve G strectomy Fully Robotic
Edelson [21] 2011 2006-2009 Philadelphia, USA CCT 287 Robotic gastric banding Gastric b nding Fully Robotic
Park [22] 2011 2007-2009 Honolulu, USA CCT 105 Robotic-assisted Roux-en-Y gastric bypass Roux-en gastric bypass NR
Scozzari [8] 2011 2006-2009 Torino, Italy CCT 110 Robotic-assisted Roux-en-Y gastric bypass Roux-en gastric bypass Fully Robotic
Curet [23] 2009 2005 Stanford, USA CCT 21 Robotic Roux-en-Y gastric bypass Roux-en gastric bypass Fully Robotic
Deng [24] 2008 2006-2007 Pasadena, USA Case series 100 Robotic-assisted Laparoscopic Roux-en-Y
gastric bypass
Roux-en gastric bypass Fully Robotic
Hubens [25] 2008 2004-2006 Antwerpen,
The Netherlands
CCT 45 Robotic Roux-en-Y gastric bypass Roux-en gastric bypass Fully Robotic
Sudan [26] 2007 NR Omaha, USA Case series 47 Robotically assisted biliopancreatic
diversion with duodenal switch
Biliopan eatic diversion with
duodena switch
Laparoscopic-Robotic
Parini [27] 2006 2000-2004 Aosta, Italy Case series 17 Laparoscopic gastric bypass performed
with the Da Vinci Intuitive Robotic System
Roux-en gastric bypass Laparoscopic-Robotic
Mohr [28] 2006 2004-2005 Stanford, USA Case series 75 Totally Robotic Laparoscopic Roux-en-Y
Gastric Bypass
Roux-en gastric bypass Fully Robotic
Yu [29] 2006 2003-2005 Houston, USA Case series 100 Robotic assistance for laparoscopic
Roux-en-Y gastric bypass
Roux-en gastric bypass Laparoscopic-Robotic
Ali [30] 2005 2002-2003 Sacramento, USA Case series 50 Robot-assisted laparoscopic Roux-en-Y
gastric bypass
Roux-en gastric bypass Laparoscopic-Robotic
Artuso [31] 2005 2001-2002 New York, USA Case series 41 Laparoscopic gastric bypass performed
with robotics







































Table 1 Characteristics of the included studies: setting and technique (Continued)
Galvani [32] 2005 2000-2004 Chicago, USA Case series 140 Robot-assisted surgery 110 Gastric bypass procedures
30 Lap band
Laparoscopic-Robotic
Sanchez [33] 2005 2004-2005 Stanford, USA RCT 25 Totally robotic laparoscopic Roux-en-Y
gastric bypass
Roux-en-Y gastric bypass Fully Robotic
Muhlmann [34] 2003 NR Innsbruck, Austria CCT 10 Robotic-assisted laparoscopic silicone
adjustable gastric banding Robotic
implantable gastric stimulator
4 silicone adjustable gastric banding Laparoscopic-Robotic
2 implantable gastric stimulator
4 silicone adjustable gastric
banding reoperation


























Abdalla [15] NR1 NR NR
Buchs [16] 43 122.8 44
Hagen [7] 42.6 NR 44.5
Tieu [17] 46.9 131.9 47.9
Vilallonga [18] 44.7 NR 48.3
Ayloo [19] 38 152 57
Diamantis [20] 39.4 NR 48.2
Edelson [21] 45 NR 45.4
Park [22] 42.2 NR 46.77
Scozzari [8] 42.6 127.5 46.7
Curet [23] 46.5 NR 45.6
Deng [24] 41.7 NR 48
Hubens [25] 42 NR 44.2
Sudan [26] 38 NR 45
Parini [27] 42.9 NR 50.3
Mohr [28] 44 NR 46.1
Yu [29] 42 NR 50
Ali [30] 42 NR 47
Artuso [31] 42.5 146.2 52.8
Galvani [32] NR NR NR
Sanchez [33] 43.3 NR 45.5
Muhlmann [34] NR NR 41.5
*Listed in chronological order.
1NR: not reported.
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screened by two authors (RCand ST) for eligibility.
When there was overlapping between multiple articles
published by the same authors and no difference in the
examined time, only the most recent trial was enclosed to
avoid double counting. The Pubmed function “related
articles” and Google Scholar database were used to search
further articles. We also searched the online database
of relevant high-impact journals such as Surgery for
Obesity and Related Diseases, Obesity, Obesity review,
International Journal of Obesity, Obesity Surgery and
Surgical Endoscopy. The references of the included
studies were evaluated for other potential trials. The
two screening authors evaluated the eligibility of each
trial.
Inclusion criteria
In this systemic review, we considered both comparative
and non-comparative studies, irrespectively of their size,
publication status and language, which included patients
who underwent robotic bariatric surgery . Comparative
studies were included if they focused on selected outcomes
of interest, irrespectively of the type of surgical approach
used for comparative group (laparoscopic or open).
Exclusion criteria
Studies in which the outcomes of interest were neither
reported nor directly or indirectly inferable.
Data extraction
Primary outcomes
surgical (conversion to open surgery, anastomotic leakage,
re-intervention for complications, mortality), bariatric
(postoperative Body Mass Index), and metabolic (type 2
DM remission) outcomes were considered.
Secondary outcomes
– Surgical ones (major and minor complication rate,
pulmonary embolism rate, deep venous thrombosis,
30-days re-admission rate, anastomotic bleeding,
gastrojejunostomy anastomotic stricture,
post-operative small bowel obstruction,
length of hospital stay, operative time).
– metabolic ones (number of patients able to
discontinue medical treatment for T2DM at the
follow-up and other obesity related morbidities
resolution or improvement such as hypertension,
sleep apnoea, gastroesophageal reflux and
degenerative arthritis).
The included CCT studies were assessed for their
methodological quality using the revised and modified
grading system of the Scottish Intercollegiate GuidelinesNetwork (SIGN) [13]; the case series assessment was
carried out using the checklist for the quality of case series
of the National Institute for Health and Clinical Excellence
(NICE) [14]. Two authors (RC and CR) independently
extracted data for the listed outcomes and assessed the
methodological quality of each study, without masking the
authors’ names.
Results
The PRISMA flow chart for systematic review is presented
in Figure 1. The initial search produced 132 potentially
relevant articles. After the titles and abstracts were
screened for relevance, 25 remaining articles were further
assessed for eligibility and 3 were excluded; 22 trials whose
characteristics are reported in Tables 1 and 2, were included
in this systematic review: 1 Randomized Controlled Trial
(RCT), 9 Clinical Controlled Trial (CCT) and 12 case series
[7,8,15-34]. We excluded the abstract of the largest
series trial of robotic-assisted bypass performed in
three high-volume centers and presented by Wilson
at the American Society for Metabolic & Bariatric
Table 3 Evaluation of methodological qualities of comparative included studies
Items/author* [7] [19] [20] [21] [22] [8] [23] [25] [33] [34]
Inclusion criteria 0 1 0 0 1 0 1 1 1 0
Exclusion criteria 0 0 0 0 0 0 0 0 0 0
Comparable demographics? 1 1 0 1 1 1 1 1 1 1
Could the number of participating centres be determined? 1 1 1 1 1 1 1 1 1 1
Could the number of surgeons who participated be determined? 1 1 1 1 1 0 0 1 1 1
Could the reader determine where the authors were on the learning
curve for the reported procedure?
0 0 1 0 0 1 0 1 1 0
Were diagnostic criteria clearly stated for clinical outcomes if required? 1 1 1 1 1 1 1 1 1 1
Was the surgical technique adequately described? 1 1 1 0 0 1 0 1 0 1
Did they try to standardize the surgical technique? 1 0 1 0 0 1 0 1 0 1
Did they try to standardize perioperative care? 0 0 0 0 0 0 0 0 0 0
Was the age and range given for patients in the Robotic group? 1 0 1 1 1 1 0 1 1 1
Did the authors address whether there were any missing data? 1 1 1 1 1 0 1 0 1 0
Was the age and range given for patients in the comparative group? 1 0 0 1 1 1 0 1 1 1
Were patients in each group treated along similar timelines? 1 1 1 1 1 1 1 1 1 0
The patients asking to enter the study, did they actually take part to it? 0 0 0 0 0 0 0 0 1 0
Were drop-out rates stated? 0 0 0 0 0 0 0 0 1 0
Were outcomes clearly defined? 1 1 1 1 1 1 1 1 1 1
Were there blind assessors? 0 0 0 0 0 0 0 0 0 0
Were there standardized assessment tools? 1 0 0 0 0 0 0 0 1 0
Was the analysis by intention to treat? 0 0 0 0 0 0 0 0 1 0
Score 12 9 10 9 10 10 7 12 15 9
Total score, 21; <8, poor quality; 8–14, fair quality; ≥15, good quality.
* Named by reference number and listed in chronological order.
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the limited data available in the abstract. [35]. The
methodological quality according to the modified grading
system of the Scottish Intercollegiate Guidelines Network
resulted of fair quality for each of the 10 comparativeTable 4 Evaluation of methodological qualities of observation
Items/author*
Case series collected in more than one centre, i.e. multi-centre study
Is the hypothesis/aim/objective of the study clearly described?
Are the inclusion andexclusion criteria (case definition) clearly reported?
Is there a clear definition of the outcomes reported?
Were data collected prospectively?
Is there an explicit statement that patients were recruited
consecutively?
Are the main findings of the study clearly described?
Are outcomes stratified? (e.g., by disease stage, abnormal test
results, patient characteristics)
Total Score
Yes = 1 No(not reported, not available) = 0.
Total score, 8; ≤3, poor quality; 4–6, fair quality; ≥7, good quality.
* Named by reference number and listed in chronological order.studies included (mean score 10.3 points) (Table 3). The
methodological quality assessment of the case series
included proved a fair quality of the selected items evaluated
with the NICE checklist (mean score 4.9 points) ( Table 4).
The pooled data included 2.781 (patients range per study:al included studies
[15] [16] [17] [18] [24] [26] [27] [28] [29] [30] [31] [32]
0 0 1 0 0 0 0 0 0 0 0 0
1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 0 1 0 0 0
1 1 1 1 1 1 1 1 1 1 1 0
0 1 1 0 0 0 0 0 1 1 0 0
0 0 1 1 1 0 1 1 1 0 0 0
0 1 1 1 1 1 1 1 1 1 1 0
0 0 0 1 1 0 1 1 1 1 1 0
3 5 7 6 6 4 6 5 7 5 4 1
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bariatric surgical treatment: 2.225 RRYGB, 86 Robotic
Sleeve gastrectomy (RSG), 421 silicone adjustable
gastric band, 47 bilio-pancreatic diversion with a duo-
denal switch and 2 implantable gastric stimulator. We
excluded from our analysis implantable gastric stimu-
lator (2 patients) and silicone adjustable gastric band
reoperation (2 patients). The definition of the robotic
approach given in the included studies was very heteroge-
neous: fully robotic, robotic, robotic-assisted and robot-
assisted laparoscopy. The dissection and the resection were
also heterogeneous and sequentially combining different
approaches: laparoscopic/robotic and only robotic.
Primary outcomes
– Surgical Outcomes: The data listed in Table 5 suggest
that robotic bariatric surgery is feasible, regardless of
the type of treatment (99.9% in RYGB – 100% in
RSG, 100% in silicone adjustable gastric band, 93.62%
in biliary pancreatic diversion with duodenal switch).
The analysis revealed a very low anastomotic leak rate
(0.29% of gastrojejunostomy and 0.05% ofTable 5 Primary outcomes
Study Intraoperative conversions 30-day reoperation
Abdalla [15] 0 1
Buchs [16] 2 2
Hagen [7] 2 1
Tieu [17] 0 NR
Vilallonga [18] 0 0
Ayloo [19] 0 1
Diamantis [20] 0 0
Edelson* [21] 0 11
Park [22] 1 1
Scozzari [8] 0 2
Curet [23] NR NR
Deng [24] NR 0
Hubens [25] 9 2
Sudan [26] 3 NR
Parini [27] 0 0
Mohr [28] 4 NR
Yu [29] 0 2
Ali [30] NR NR
Artuso [31] NR NR
Galvani [32] NR NR
Sanchez [33] 1 NR
Muhlman [34] NR NR
* Listed in chronological order.
1NR: not reported.jejunojejunostomy in RYGB, 0% in SG, 0.25% in
silicone adjustable gastric band, 8.51% in biliary
pancreatic diversion with duodenal switch).
The 30-day post-operative reoperation rate was
very low (1.14% in RYGB and 1.16% in SG) (Table 5).
No study reported any case of 30-day postoperative
mortality (Table 5).
– Bariatric outcome (postoperative Body Mass Index):
only few trials reported the reduced mean BMI after
3 months from the RYGB [7,8,18,24,27,28] and
SG [20] (Table 5).
– Metabolic outcomes: none of the studies reported
data on the metabolic outcome.
Secondary outcomes
– Surgical Outcomes: major complication rates were
4,26% in RYGB and 1,2% in SG; minor complication
rates were 1% in RYGB and 0% in SG; Pulmonary
embolism rates were 0,71% in RYGB 0% in RSG;
deep venous thrombosis rates were 0,37% in RYGB
and 0% in SG; 30-day re-admission rates were 4,84%
in RYGB and 0% in SG (Table 6). 15 cases ofs 30-day postoperative mortality Mean body mass index







0 reduced of 31.3%
0 NR
0 NR






















Readmissions in the first
30 postoperative days
Abdalla [15] 1 5 0 0 NR1
Buchs [16] 24 (not classified) 7 2 2
Hagen [7] 23 (not classified) NR NR NR
Tieu [17] 45 102 2 3 67
Vilallonga [18] 1 case NR NR NR NR
Ayloo [19] NR NR NR 0
Diamantis [20] 0 (not classified) 0 0 0
Edelson [21] NR NR NR NR
Park [22] 10 (not classified) 0 0 0
Scozzari [8] 4 14 1 NR NR
Curet [23] 3 (not classified) NR NR NR
Deng [24] 4 7 NR NR 3
Hubens [25] NR NR NR NR NR
Sudan [26] NR NR NR NR NR
Parini [27] 0 0 0 0 0
Mohr [28] 6 7 NR NR NR
Yu [29] NR NR 1 NR NR
Ali [30] NR NR NR NR NR
Artuso [31] NR NR NR NR NR
Galvani [32] NR NR NR NR NR
Sanchez [33] NR NR NR NR NR
Muhlmann [34] NR NR NR NR NR
* Listed in chronological order.
1NR: not reported.
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1.873 RYGB while none were reported in SG
(Tables 7, 8). Gastrojejunostomy anastomotic
stricture rate was 1,23% in RYGB. Post-operative
small bowel obstruction rates were 1,17% in
Roux-en-Y gastric bypass and 0% in sleeve gastrectomy
(Tables 7, 8). The mean hospital stay ranged between
2.72 and 7.4 days in RYGB and between 2.6 and 4 days
in SG (Table 9). The mean operative time ranged
between 130.8 and 295 min. in RYGB and between
95 and 135 min. in SG (Table 9).
– Metabolic outcomes: none of the studies reported
this outcome.
Discussion
The present study revealed slightly different outcomes and
complication rates between the traditional laparoscopic
approach and the robotic one. Data from a RCT collected
after laparoscopic gastric bypass showed that 1-year
mortality is about 0.9%, Major perioperative complications
(hemorrhage, obstruction, internal herniation, or renal
insufficiency) occur in 6.3% of patients and late (> 30 dayspostoperatively) major complications, more often stenosis
or strictures, in 26.1% of them [36]. The results of this
review demonstrated that the robotic approach is safe and
feasible in all types of bariatric surgical procedures. The
overall post-operative complication rate was very low; in
particular the anastomotic leak rate (gastro-jejunostomy
and jejuno-jejunostomy in RYGB) and the gastric staple
line leak rate were very low and no deaths were reported.
The analysis of these selected trials on the robotic bariatric
surgery did not show any significant results about the
bariatric and the metabolic outcomes. Our results were in
line with the ones presented in 2012 by Wilson et al. at the
Annual Meeting of the American Society for Metabolic &
Bariatric Surgery in San Diego [35]. In this trial the authors
enrolled 1,695 patients undergoing robotic-assisted
RYGB surgery; the post-operative complications were
17 bowel obstructions, 5 wound infections and 18
cases of bleeding. The hospital readmissions rate was
4.8% and re-intervention rate was 2.7%. Leak and
anastomotic stricture rates were very low: 0.3% and
0.2% respectively. No death was reported. “This report
of the largest series of robotic-assisted bypasses from
Table 7 Surgical complications after gastric bypass






Abdalla [15] 0 0 0 0 0
Buchs [16] 0 0 3 NR3 1
Hagen [7] 0 0 0 3 NR
Tieu [17] 1 1 7 9 19
Park [22] 2 0 2 0 0
Scozzari [8] 2 0 3 0 1
Curet [23] 0 0 0 0 0
Deng [24] 1 0 4 3 0
Hubens [25] 0 0 2 0 1
Parini [27] 0 0 0 0 0
Mohr [28] 0 0 2 0 0
Yu [29] 0 0 2 0 0
Ali [30] NR NR NR NR NR
Artuso [31] 1 0 0 0 0
Galvani [32] NR NR NR NR NR
Sanchez [33] NR NR NR NR NR
* Listed in chronological order.
3NR: not reported.
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rates in the first 30 days. It reveals zero 30-day mortality,
an exceptionally low leak rate, and provides strong
evidence that Robot-Assisted RYGB (RARYGB) has
extremely safe and reproducible outcomes” [35]. Robotic
surgery allowed the reduction of the postoperative compli-
cations, especially the anastomotic dehiscence. The low
anastomotic leak rate after robotic bypass can be partially
explained by the improved accuracy and precision of
intracorporeal suturing compared to the traditional
laparoscopic approach. 5 cm proximal to the anastomosis,
an antireflux longitudinal valve is fashioned with suture
stitches 1 cm apart from each other. In USA the RARYGB
represent the first line choice of bariatric surgery, but
because of its “complexity”, this operation has always been
challenged by alternative surgical procedures [37].
Safety of gastric bypass was demonstrated and its
effectiveness in the long term weight loss maintenance
as well, nevertheless it associates with a long learning
curve and it is not free fromTable 8 Surgical complications after sleeve gastrectomy and
Surgical treatment Study Suture leak Suture str
Sleeve gastrectomy Vilallonga [18] 0 0
Ayloo [19] 0 1
Diamantis [20] 0 0
Duodenal switch Sudan [26] 4 0complications [38,39]. Kim et al. concluded that the
use of the robot is ideal in performing RYGB [40]. This
technique associates with shorter learning curve especially
in performing delicate and precise manoeuvres such
as fine dissections and suturing. Indeed it is widely
recognized that robotic bariatric surgery, in particular
RRYGB, has a steeper learning curve than laparoscopic
approach and 20 cases may be enough to pass the basic
learning phase [41]. Moreover this technique, unlike
laparoscopic surgery, can be used in high-risk obese
patients with difficult anatomy without compromising
the surgical performance and outcomes [40]. The best
results derived from the RSG that showed even fewer
postoperative complications and no mortality, but the
use of the robot in performing sleeve gastrectomy is
still controversial, and not largely spread among bariatric
surgeons yet. Recently few case series on this technique
were published [19,20]. Robotic approach was demonstrated
associating with shorter learning curve compared to the
traditional laparoscopic techniques [37]. A poster presentedduodenal switch









Length of hospital stay
Mean ± Standard deviation (days)
Abdalla [15] NR1 NR
Buchs [16] 295.2 7.2 ± 2.5
Hagen [7] 293 7.4 ± 2.6
Tieu [17] 155 NR
Vilallonga [18] 130.2 NR
Ayloo [19] 135 2.6
Diamantis [20] 95.5 4
Edelson [21] 91.5 1.3
Park [22] 169 3.41 ± 7.03
Scozzari [8] 247.5 7.8
Curet [23] 181.7 3
Deng [24] 186.3 1.5
Hubens [25] 242.2 4.7
Sudan [26] 514 NR
Parini [27] 201 9
Mohr [28] 140 2.9
Yu [29] 254 NR
Ali [30] NR NR
Artuso [31] 289 4.6
Galvani [32] NR NR
Sanchez [33] 130.8 2.72
Muhlman [34] 137 3
*Listed in chronological order.
1NR: not reported.
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American Gastrointestinal and Endoscopic Surgeons
(SAGES) compared 277 laparoscopic sleeve Gastrectomy
(LSG) to 40 RSG. The mean operative time was signifi-
cantly shorted (91 minutes) for LSG compared to the RSG
(113 minutes) (p-0.002) No differences were revealed in
overall mean hospital stay (2.4 days in the LSG group and
2.5 in the RSG group) (p = 0.86). The overall mean 90-day
complication rate requiring readmission was significantly
lower in patients who had undergone RSG (12.3% in the
LSG group and 5% in RSG group) (p = <.001) [42].
Conclusion
Robotic assistance is used in a small percentage of bariatric
procedures in the US. The major limitation of our analysis
is the lack of studies and their low quality, small sample
size,, heterogeneity of enrolled patients and the lack of data
from metabolic and bariatric outcomes. Despite the use of
the robot, the majority of these cases are completed with
stapled anastomosis. The assumption that robotic surgery
is superior in complex cases is not supported from actual
evidence. According to our experience the major strengthof the robotic surgery is strongly facilitating some of the
surgical steps (gastro-jejunostomy and jejunojejunostomy
anastomosis in the robotic Roux-en-Y gastric bypass or the
vertical gastric resection in the robotic sleeve gastrectomy).
According to our experience the major disadvantage of the
robotic bariatric surgery “still remains the high operational
and acquisition cost of the system” [37].
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